Nutritional and Metabolic Diseases

All Conditions

Malnutrition

Nutrition Disorders

Micronutrients

All Drugs and Chemicals

Nootropic Agents

Gastrointestinal Agents

Lipid Regulating Agents

Bone Density Conservation Agents

Anti-Infective Agents

Vitamins

Other Dietary Supplements

Amino Acids

Mineral

Iron

Calcium

Selenium

Chromium

Trace Elements

Biotin

Choline

Manganese

Calcium, Dietary

Zinc

Copper

Iodine

Cadexomer iodine

Molybdenum

Carnitine

Taurine

Vitamin B7

Copper Supplement

industrialized oral supplementation (IOS) and tube feeding regimen (TFR) with Nutren 1.0 or Jr (Nestlé-Clinical Nutrition).

The oral and tube supplement offered was Nutren Jr® (for patients aged 1 - 9 years) or Nutren 1.0- Nestlé Clinical Nutrition-Brazil (for those aged 10 years or over). This supplement was a whole powder formulation that presented a macro composition of 52% carbohydrates, 12% proteins and 36% lipids. Its vitamins were A, D, E, K, B complex, biotin and choline; its trace elements were iron, copper, zinc, manganese, selenium, chromium and molybdenum; its macroelements were potassium, calcium, sodium, chlorine, iodine, magnesium and phosphorus; and it contained taurine and L-carnitine presenting 1.0 kcal/ml.

industrialized oral supplementation (IOS) and tube feeding regimen (TFR) with Nutren

CONTEXT AND OBJECTIVE: Tumor and its therapy have adverse effects on the nutritional status of cancer patients, leading to nutritional support. The aim was to study enteral nutrition indications, as well as its compliance and the impact on nutritional status.

DESIGN AND SETTING: Clinical trial, IOP, Unifesp-EPM.

METHODS: Patients older than 1 year followed during anticancer therapy were included from January 2002 to January 2004. They received industrialized oral supplementation - Nutren 1.0 or Jr (IOS) and were followed on a weekly basis and reevaluated on weeks 3, 8 and 12: at these times, if inadequate outcome was observed, tube feeding with the same supplement (TFR) was indicated.

Enteral Nutrition in Cancer Patients

Enteral Nutrition Support in Children and Adolescents With Cancer: a Non-randomized Controlled Clinical Trial

Grupo de Apoio ao Adolescente e a Crianca com Cancer

Adriana Garófolo

CONTEXT AND OBJECTIVE: Tumor and its therapy have adverse effects on the nutritional status of cancer patients, leading to nutritional support. The aim was to study enteral nutrition indications, as well as its compliance and the impact on nutritional status.

DESIGN AND SETTING: Clinical trial, IOP, Unifesp-EPM. METHODS: Patients older than 1 year followed during anticancer therapy were included from January 2002 to January 2004. They received industrialized oral supplementation - Nutren 1.0 or Jr (IOS) and were followed on a weekly basis and reevaluated on weeks 3, 8 and 12: at these times, if inadequate outcome was observed, tube feeding with the same supplement (TFR) was indicated.

Enteral Nutrition in Cancer Patient

Enteral Nutrition Support in Children and Adolescents With Cancer: a Non-randomized Controlled Clinical Trial.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Enteral Nutrition in Cancer Patients	NCT01304446	Malnutrition Cancer	industrialized ...	1 Year -	Grupo de Apoio ao Adolescente e a Crianca com Cancer
Enteral Nutrition in Cancer Patients	NCT01304446	Malnutrition Cancer	industrialized ...	1 Year -	Grupo de Apoio ao Adolescente e a Crianca com Cancer
Enteral Nutrition in Cancer Patient	NCT01302509	Malnutrition Cancer Pediatric	industrialized ...	1 Year -	Grupo de Apoio ao Adolescente e a Crianca com Cancer
Enteral Nutrition in Cancer Patients	NCT01304446	Malnutrition Cancer	industrialized ...	1 Year -	Grupo de Apoio ao Adolescente e a Crianca com Cancer

Spots Global Cancer Trial Database for industrialized oral supplementation (ios) and tube feeding regimen (tfr) with nutren